Mercedes-Benz USA, LLC
Summary
NHTSA campaign 22V732: Mercedes-Benz USA, LLC recalled for a safety defect. A seat with a seatback lock failure may not properly restrain occupants, increasing the risk of injury during a crash.
Details
Source
nhtsa
External ID
22V732
Action Date
2022-10-03
Status
Ongoing
Category
vehicle
Product Description
Mercedes-Benz USA, LLC (MBUSA) is recalling certain 2021 AMG GLS63, 2020-2022 GLS450 and GLS580 vehicles. Due to a manufacturing error, the locks on the third-row seatbacks may fail in the event of a crash.
Company
Context & Analysis
Mercedes-Benz USA, LLC has 149 FDA actions in our database.
Frequently Asked Questions
How often does Mercedes-Benz USA, LLC have FDA actions?
Mercedes-Benz USA, LLC has 149 FDA actions in our database, including 0 recalls and 0 device clearances.
Where can I find the official FDA record?
The official record is available on FDA.gov. Use the link above to view the complete official filing. You can also use the openFDA API to query this record programmatically.
Want to know the moment something like this happens?
Get alerts for vehicle